University of Calgary’s Dr. Mark Giembycz is ‘powered by breathing’


Important work is continuing in Dr. Mark Giembycz’s lab at the University of Calgary.

Giembycz is studying how drugs that are currently available — or potentially new drugs — can help treat asthma, an illness that is the leading cause of emergency room visits for children in Alberta and Canada.

He is also studying how those drugs will also benefit patients who are suffering from chronic obstructive pulmonary disease (COPD), along with other lung diseases. His work is also being financially supported by those who have generously donated to The Lung Association, Alberta & NWT (“TLA”).

“It may seem kind of bizarre, but even though drug companies make drugs and are effective for certain individuals, many of the drugs seem to work without us understanding the mechanizm,” said Giembycz.

“What we do is try to pin down how these drugs actually work in hopes that we could make those new drugs better drugs in the future.”

Without the funding from charities like TLA, Giembycz said his team would face extreme challenges in finding improved treatments for lung diseases like COPD and asthma.

“Funding for research across the board is difficult to get, despite having very important questions to ask or more problems to actually solve,” said the Calgary-based lung health researcher.

“Some of the research would suffer without The Lung Association.”

Donate today to support other important research projects like Giembycz’s work. Click here to donate today!

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: